EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

298. Oral vs Intravenous Antibiotics in the Treatment of Periprosthetic Joint Infections

Angelina Liddy, Neeku Salehi, Eric Smith, Javad Parvizi, Daniel Taupin, Elizabeth Gancher, Brooke Olin, Megan Gorleski, Katherine Belden

Open Forum Infectious Diseases · 11.01.2026 · 13 (Supplement_1)

DOI: 10.1093/ofid/ofaf695.100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 11.01.2026. Verfasst von Angelina Liddy und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Historically in the United States, periprosthetic joint infection (PJI) has been managed with intravenous (IV) antibiotics. A number of randomized controlled trials (RCTs) have demonstrated non-inferiority of oral (PO) antibiotics compared to IV therapy in the treatment of bone and joint infections. Our study is a non-inferiority trial comparing PO and IV antibiotic regimens in primary hip and knee PJIs.

Methods

This is an ongoing, multi-center, parallel-group, unblinded, non-inferiority RCT approved by our institution's Institutional Review Board with enrollment beginning December, 2020. Participants include adults with a primary hip or knee arthroplasty, diagnosed with PJI by International Consensus Meeting criteria, and treated with surgery. Exclusion criteria include prior revision, the need for IV antibiotics for other indications, or a lack of an antibiotic option in either arm. Patients were randomized to receive either PO or IV antibiotics for six weeks. PO rifampin and follow-on antibiotic suppression was allowed in both arms. The primary study end point is failure at one year by Musculoskeletal Infection Society criteria. Descriptive analysis is provided for the preliminary findings.

Results

Forty-five patients completed one-year follow up with 27 and 18 in the PO and IV groups, respectively. They had a median age of 65 years, 57% were male, 8.8% were of non-white race. Twenty patients (44.4%) were treated for primary hip PJI, and 25 (55%) for primary knee PJI. Twenty-five (55%) underwent a two-stage exchange arthroplasty, 13 (26%) had debridement with implant retention, and 8 (17%) had single-stage exchange arthroplasty. The most commonly treated infections were Staphylococcus spp. (n= 21) and culture negative infection (n=12). There were five treatment failures: two (15.4%) in the IV group and three (12.5%) in the oral group. Of IV patients, 44% (n=8) had a catheter complication.

Conclusion

Preliminary findings in 45 patients who completed one year of follow up suggest that PO antibiotic regimens may be a viable and safe alternative to IV therapy in the treatment of primary hip and knee PJI. Study enrollment is ongoing across multiple centers with a larger patient cohort expected to provide a more definitive assessment of this important clinical question. Disclosures All Authors: No reported disclosures

Zitieren

APA

Liddy, A., Salehi, N., Smith, E., Parvizi, J., Taupin, D., Gancher, E., Olin, B., Gorleski, M., & Belden, K. (2026). 298. Oral vs Intravenous Antibiotics in the Treatment of Periprosthetic Joint Infections. Open Forum Infectious Diseases, 13(Supplement_1). https://doi.org/10.1093/ofid/ofaf695.100

Vancouver

Liddy A, Salehi N, Smith E, Parvizi J, Taupin D, Gancher E, et al. 298. Oral vs Intravenous Antibiotics in the Treatment of Periprosthetic Joint Infections. Open Forum Infectious Diseases. 2026;13(Supplement_1). doi:10.1093/ofid/ofaf695.100

BibTeX
@article{Liddy2026,
  author = {Liddy, Angelina and Salehi, Neeku and Smith, Eric and Parvizi, Javad and Taupin, Daniel and Gancher, Elizabeth and Olin, Brooke and Gorleski, Megan and Belden, Katherine},
  title = {298. Oral vs Intravenous Antibiotics in the Treatment of Periprosthetic Joint Infections},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {Supplement_1},
  doi = {10.1093/ofid/ofaf695.100}
}
Kostenlos starten →